\-\ Texto\\:\\ \ \(0\)\
\-\ current\\ treatment\\ for\\ gbm\\ is\\ palliative\\ to\\ prolong\\ survival\\ without\\ therapy\\ patients\\ with\\ gbm\\ usually\\ die\\ with\\ 3\\ months\\.\\ patient\\ treated\\ with\\ optimal\\ therapy\\ \\,\\ including\\ surgical\\ resection\\,\\ radiation\\ therapy\\ and\\ chemotherapy\\ have\\ a\\ median\\ survival\\ of\\ one\\ year\\.\ \(0\)\
\-\ males\\ had\\ a\\ slight\\ preponderance\\ over\\ females\\ with\\ a\\ ratio\\ of\\ 5\\:1\\.\\ gbm\\ may\\ \\ manifest\\ at\\ any\\ age\\ with\\ peak\\ incidence\\ 45\\-70\\ yrs\\.\ \(0\)\
\-\ multiple\\ mr\\ images\\ taken\\ with\\ and\\ without\\ contrast\\ illustrates\\ a\\ cerebral\\ mass\\ located\\ within\\ corpus\\ callosum\\ with\\ surrounding\\ edema\\.\ \(0\)\
\-\ glioblastom\\ multiforme\\ \\(gbm\\)\ \(0\)\
\-\ gbm\ \(0\)\
\-\ cerebral\\ abscess\ \(11\)\
\-\ cns\\ lymphoma\ \(0\)\
\-\ demyelinating\\ processes\ \(0\)\
\-\ anaplastic\\ astrocytoma\ \(4\)\
\-\ metastasis\ \(206\)\
\-\ 51\\ year\\ old\\ with\\ symptoms\\ of\\ increased\\ intacranial\\ presure\\ for\\ approximately\\ 2\\ months\\.\\ \\ patient\\ complaineed\\ of\\ vomitting\\,\\ early\\ morning\\ headache\\,\\ seizures\\ and\\ personality\\ changes\\.\ \(0\)\
\-\ patient\\ underwent\\ surigal\\ excision\\ of\\ the\\ cerebral\\ mass\\ followed\\ by\\ post\\ operative\\ radiation\\ therapy\\.\\ \\ surgery\\ was\\ without\\ complications\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ gbm\\:\\ 0\\.48816669120992007\ \(0\)\
\-\ therapy\\:\\ 0\\.21221726762346466\ \(0\)\
\-\ cerebral\\:\\ 0\\.1919183747579203\ \(0\)\
\-\ survival\\:\\ 0\\.18023496698708188\ \(0\)\
\-\ preponderance\\:\\ 0\\.14766897359479383\ \(0\)\
\-\ glioblastom\\:\\ 0\\.14766897359479383\ \(0\)\
\-\ intacranial\\:\\ 0\\.14766897359479383\ \(0\)\
\-\ complaineed\\:\\ 0\\.14766897359479383\ \(0\)\
\-\ surigal\\:\\ 0\\.14766897359479383\ \(0\)\
\-\ without\\:\\ 0\\.14611487530564216\ \(0\)\
\-\ with\\:\\ 0\\.1446478795399526\ \(0\)\
\-\ presure\\:\\ 0\\.1411055877456135\ \(0\)\
\-\ prolong\\:\\ 0\\.13283669949017812\ \(0\)\
\-\ die\\:\\ 0\\.12332201967776292\ \(0\)\
\-\ radiation\\:\\ 0\\.12238199941622921\ \(0\)\
\-\ vomitting\\:\\ 0\\.1200737026793244\ \(0\)\
\-\ personality\\:\\ 0\\.1186652233082731\ \(0\)\
\-\ optimal\\:\\ 0\\.11505313142232755\ \(0\)\
\-\ manifest\\:\\ 0\\.11039633505283772\ \(0\)\
\-\ months\\:\\ 0\\.107496671189778\ \(0\)\
\-\ yrs\\:\\ 0\\.10278824472011308\ \(0\)\
\-\ demyelinating\\:\\ 0\\.10133766571221113\ \(0\)\
\-\ anaplastic\\:\\ 0\\.10133766571221113\ \(0\)\
\-\ palliative\\:\\ 0\\.09958597981886586\ \(0\)\
\-\ illustrates\\:\\ 0\\.09958597981886586\ \(0\)\
\-\ multiforme\\:\\ 0\\.09622485887093271\ \(0\)\
\-\ median\\:\\ 0\\.09556406094822198\ \(0\)\
\-\ males\\:\\ 0\\.09524350985474128\ \(0\)\
\-\ peak\\:\\ 0\\.09462084457921675\ \(0\)\
\-\ females\\:\\ 0\\.09288482887223051\ \(0\)\
\-\ ratio\\:\\ 0\\.09261276698498716\ \(0\)\
\-\ morning\\:\\ 0\\.09156806250144289\ \(0\)\
\-\ processes\\:\\ 0\\.09082652974182229\ \(0\)\
\-\ of\\:\\ 0\\.09035094004732154\ \(0\)\
\-\ patient\\:\\ 0\\.09009899766828577\ \(0\)\
\-\ 51\\:\\ 0\\.08815958715237183\ \(0\)\
\-\ callosum\\:\\ 0\\.08697462159930591\ \(0\)\
\-\ cns\\:\\ 0\\.08623024671848674\ \(0\)\
\-\ corpus\\:\\ 0\\.08418280972654667\ \(0\)\
\-\ current\\:\\ 0\\.08086180602651938\ \(0\)\
\-\ slight\\:\\ 0\\.08086180602651938\ \(0\)\
\-\ incidence\\:\\ 0\\.07948599528662643\ \(0\)\
\-\ operative\\:\\ 0\\.07745994178689072\ \(0\)\
\-\ seizures\\:\\ 0\\.07537797354677517\ \(0\)\
\-\ taken\\:\\ 0\\.07378449443359232\ \(0\)\
\-\ located\\:\\ 0\\.07304296167397172\ \(0\)\
\-\ excision\\:\\ 0\\.07280314541740089\ \(0\)\
\-\ complications\\:\\ 0\\.07072117717728536\ \(0\)\
\-\ mass\\:\\ 0\\.0705414976760312\ \(0\)\
\-\ astrocytoma\\:\\ 0\\.06970702713417683\ \(0\)\
\-\ metastasis\\:\\ 0\\.06767711905620055\ \(0\)\
\-\ early\\:\\ 0\\.06656031066170122\ \(0\)\
\-\ including\\:\\ 0\\.06608183342538347\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.0655662706991563\ \(0\)\
\-\ headache\\:\\ 0\\.06365404399104564\ \(0\)\
\-\ underwent\\:\\ 0\\.06360901669846641\ \(0\)\
\-\ followed\\:\\ 0\\.062354900481367555\ \(0\)\
\-\ surrounding\\:\\ 0\\.06158296319873071\ \(0\)\
\-\ mr\\:\\ 0\\.05974706073636705\ \(0\)\
\-\ any\\:\\ 0\\.05967637371904017\ \(0\)\
\-\ abscess\\:\\ 0\\.05929301820589081\ \(0\)\
\-\ resection\\:\\ 0\\.05919002336481915\ \(0\)\
\-\ approximately\\:\\ 0\\.058918531864694895\ \(0\)\
\-\ usually\\:\\ 0\\.058130353403260726\ \(0\)\
\-\ age\\:\\ 0\\.05797087131278515\ \(0\)\
\-\ treated\\:\\ 0\\.05750164132107464\ \(0\)\
\-\ and\\:\\ 0\\.05724171038749952\ \(0\)\
\-\ year\\:\\ 0\\.05691366508788592\ \(0\)\
\-\ for\\:\\ 0\\.055974033512437495\ \(0\)\
\-\ changes\\:\\ 0\\.05580539144507711\ \(0\)\
\-\ edema\\:\\ 0\\.055072563652981424\ \(0\)\
\-\ lymphoma\\:\\ 0\\.05499314909674965\ \(0\)\
\-\ one\\:\\ 0\\.052867986201051036\ \(0\)\
\-\ patients\\:\\ 0\\.051945319030816194\ \(0\)\
\-\ over\\:\\ 0\\.05134412999625195\ \(0\)\
\-\ symptoms\\:\\ 0\\.05052226307053608\ \(0\)\
\-\ post\\:\\ 0\\.05024419216215905\ \(0\)\
\-\ increased\\:\\ 0\\.04993213813712248\ \(0\)\
\-\ surgery\\:\\ 0\\.04964495198986045\ \(0\)\
\-\ may\\:\\ 0\\.04646752208479023\ \(0\)\
\-\ have\\:\\ 0\\.04612802381859043\ \(0\)\
\-\ had\\:\\ 0\\.04600631421329581\ \(0\)\
\-\ multiple\\:\\ 0\\.04516465070790512\ \(0\)\
\-\ surgical\\:\\ 0\\.04487940453844076\ \(0\)\
\-\ contrast\\:\\ 0\\.04486527332737767\ \(0\)\
\-\ treatment\\:\\ 0\\.04398561100322863\ \(0\)\
\-\ images\\:\\ 0\\.042712591010485225\ \(0\)\
\-\ within\\:\\ 0\\.04252815337621882\ \(0\)\
\-\ by\\:\\ 0\\.03921217891685861\ \(0\)\
\-\ at\\:\\ 0\\.03487732829918902\ \(0\)\
\-\ was\\:\\ 0\\.03218079644114374\ \(0\)\
\-\ old\\:\\ 0\\.027328409819227916\ \(0\)\
\-\ is\\:\\ 0\\.025287458778724063\ \(0\)\
\-\ to\\:\\ 0\\.023084382643967814\ \(0\)\
\-\ the\\:\\ 0\\.01842482793737585\ \(0\)\
